GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (FRA:1FG) » Definitions » Shiller PE Ratio

FibroGen (FRA:1FG) Shiller PE Ratio : (As of May. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is FibroGen Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


FibroGen Shiller PE Ratio Historical Data

The historical data trend for FibroGen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Shiller PE Ratio Chart

FibroGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

FibroGen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of FibroGen's Shiller PE Ratio

For the Biotechnology subindustry, FibroGen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroGen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroGen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where FibroGen's Shiller PE Ratio falls into.



FibroGen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

FibroGen's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, FibroGen's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.304/131.7762*131.7762
=-0.304

Current CPI (Mar. 2024) = 131.7762.

FibroGen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.282 100.560 0.370
201409 -0.551 100.428 -0.723
201412 -0.694 99.070 -0.923
201503 -0.721 99.621 -0.954
201506 0.740 100.684 0.969
201509 -0.659 100.392 -0.865
201512 -0.780 99.792 -1.030
201603 -0.404 100.470 -0.530
201606 0.312 101.688 0.404
201609 -0.339 101.861 -0.439
201612 -0.465 101.863 -0.602
201703 -0.449 102.862 -0.575
201706 -0.409 103.349 -0.521
201709 -0.268 104.136 -0.339
201712 -0.228 104.011 -0.289
201803 -0.405 105.290 -0.507
201806 -0.240 106.317 -0.297
201809 -0.429 106.507 -0.531
201812 0.202 105.998 0.251
201903 -0.469 107.251 -0.576
201906 1.115 108.070 1.360
201909 -0.518 108.329 -0.630
201912 -1.008 108.420 -1.225
202003 -0.805 108.902 -0.974
202006 -0.844 108.767 -1.023
202009 0.297 109.815 0.356
202012 -0.526 109.897 -0.631
202103 -0.655 111.754 -0.772
202106 -1.204 114.631 -1.384
202109 0.459 115.734 0.523
202112 -1.283 117.630 -1.437
202203 -0.617 121.301 -0.670
202206 -0.738 125.017 -0.778
202209 -0.990 125.227 -1.042
202212 -0.661 125.222 -0.696
202303 -0.757 127.348 -0.783
202306 -0.831 128.729 -0.851
202309 -0.609 129.860 -0.618
202312 -0.523 129.419 -0.533
202403 -0.304 131.776 -0.304

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


FibroGen  (FRA:1FG) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


FibroGen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of FibroGen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroGen (FRA:1FG) Business Description

Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen (FRA:1FG) Headlines

No Headlines